Large Volume Parenteral Market

Large volume parenterals or LVPs (sometimes called large volume injections) are aqueous solutions usually supplied in volumes of at least 100 ml with sizes of 250 ml, 500 ml, 1000 ml, 3000 ml, and 5000 ml most common. Directions usually recommend that large quantities be administered. Parenteral preparations are sterile, solid dosage form or pyrogen-free liquids, which contain one or more number of active ingredients boxed in single or multi dose containers. They are meant to be administered either by infusion, transplantation or injection in the body. Parenteral formulations are classified into small and large based on their volume. Small volume parenteral formulations are 100ml or more and can be given as single or multi dose, whereas large volume parenteral preparations are more than 100ml, intended for single use.

Large Volume Parenteral Market contains market size and forecasts of Large Volume Parenteral (LVP) in global, including the following market information:

Global Large Volume Parenteral (LVP) Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global Large Volume Parenteral (LVP) Market Sales, 2017-2022, 2023-2028, (M Units)

Global top five Large Volume Parenteral (LVP) companies in 2021 (%)

The global Large Volume Parenteral (LVP) market was valued at 10830 million in 2021 and is projected to reach US$ 14180 million by 2028, at a CAGR of 3.9% during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Soft Bag LVP Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Large Volume Parenteral (LVP) include Baxter Healthcare, Kelun Pharma, B. Braun, Fresenius, Teva Pharmaceutical Industries, Pfizer (Hospira), Ostuka Pharmaceutical, CR Double-Crane and Pisa, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Large Volume Parenteral (LVP) manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Large Volume Parenteral (LVP) Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (M Units)

Global Large Volume Parenteral (LVP) Market Segment Percentages, by Type, 2021 (%)

• Soft Bag LVP
• Plastic Bottle LVP
• Glass Bottle LVP

Global Large Volume Parenteral (LVP) Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (M Units)

Global Large Volume Parenteral (LVP) Market Segment Percentages, by Application, 2021 (%)

• Basic Infusion
• Therapeutic Infusion
• Nutritious Infusion

Global Large Volume Parenteral (LVP) Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (M Units)

Global Large Volume Parenteral (LVP) Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

• Key companies Large Volume Parenteral (LVP) revenues in global market, 2017-2022 (Estimated), ($ millions)
• Key companies Large Volume Parenteral (LVP) revenues share in global market, 2021 (%)
• Key companies Large Volume Parenteral (LVP) sales in global market, 2017-2022 (Estimated), (M Units)
• Key companies Large Volume Parenteral (LVP) sales share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Baxter Healthcare
• Kelun Pharma
• B. Braun
• Fresenius
• Teva Pharmaceutical Industries
• Pfizer (Hospira)
• Ostuka Pharmaceutical
• CR Double-Crane
• Pisa
• Huaren
• Patheon
• Beximco Pharma
• Albert David
• PSI Ltd
• Ozon Pharmaceuticals
• BAG Healthcare
• BML Parenteral Drugs